NORCROSS, Ga., Dec. 9—MediPurpose™ has recently renewed contracts with group purchasing organizations (GPOs) Novation, AmeriNet, Consorta and MedAssets for provision of SurgiLance® Safety Lancets, ensuring the company's continuing ability to serve the acute care market.
"These key renewals are a vote of confidence in the quality of our medical product line," said MediPurpose President and COO Randy Prather. "SurgiLance® Safety Lancets are used on a daily basis in the acute care environment by hospitals which turn to SurgiLance® for its unmatched quality and reliability."
SurgiLance® Safety Lancets are used for blood sampling at the point of care. MediPurpose offers six, color-coded lancets (four needles and two blades) with varying depths and gauges.
In the United States, group purchasing organizations provide a critical link to hospitals and other acute care facilities for distributors of medical products such as the SurgiLance® Safety Lancet. The recent renewals are evidence of the product's adoption across the acute care market, said Prather.
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and the United Kingdom.
Known for its innovation of the SurgiLance® Safety Lancet, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor.
MediPurpose also offers angel funding, medical product development and medical device consulting for medical device inventors and medical product companies seeking entrance or expansion into the medical device markets.
For more information about MediPurpose's medical products, medical distribution channel management services and medical product development services, please visit www.medipurpose.com.
© 2012 MediPurpose Private Limited | About Us | Contact Us | Terms of Use
Join MediPurpose on 
